Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 20;3(2):e002377.
doi: 10.1136/bmjopen-2012-002377. Print 2013.

The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: the randomised CopenHeartRFA trial protocol

Signe Stelling Risom  1 , Ann-Dorth Olsen Zwisler, Trine Bernholdt Rasmussen, Kirstine Lærum Sibilitz, Jesper Hastrup Svendsen, Christian Gluud, Jane Lindschou Hansen, Per Winkel, Lau Caspar Thygesen, Merja Perhonen, Jim Hansen, Sandra B Dunbar, Selina Kikkenborg Berg
Affiliations

The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: the randomised CopenHeartRFA trial protocol

Signe Stelling Risom et al. BMJ Open. .

Abstract

Introduction: Atrial fibrillation affects almost 2% of the population in the Western world. To preserve sinus rhythm, ablation is undertaken in symptomatic patients. Observational studies show that patients with atrial fibrillation often report a low quality of life and are less prone to be physically active due to fear of triggering fibrillation. Small trials indicate that exercise training has a positive effect on exercise capacity and mental health, and both patients with recurrent atrial fibrillation and in sinus rhythm may benefit from rehabilitation in managing life after ablation. No randomised trials have been published on cardiac rehabilitation for atrial fibrillation patients treated with ablation that includes exercise and psychoeducational components.

Aim: To test the effects of an integrated cardiac rehabilitation programme versus treatment as usual for patients with atrial fibrillation treated with ablation. METHODS AND ANALYSIS DESIGN: The trial is a multicentre parallel arm design with 1:1 randomisation to the intervention and control group with blinded outcome assessment. 210 patients treated for atrial fibrillation with radiofrequency ablation will be included. The intervention consists of a rehabilitation programme including four psychoeducative consultations with a specially trained nurse and 12 weeks of individualised exercise training, plus the standard medical follow-up. Patients in the control group will receive the standard medical follow-up. The primary outcome measure is exercise capacity measured by the VO(2) peak. The secondary outcome measure is self-rated mental health measured by the Short Form 36 questionnaire. Postintervention, qualitative interviews will be conducted in 10% of the intervention group.

Ethics and dissemination: The protocol is approved by the regional research ethics committee (number H-1-2011-135), the Danish Data Protection Agency (reg. nr. 2007-58-0015) and follows the latest version of the Declaration of Helsinki. The results will be published in peer-reviewed journals and may possibly impact on rehabilitation guidelines.

Trial registration: Clinicaltrials.gov identifier: NCT01523145.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The CopenHeartRFA trial. Mixed methods research design. Embedded Experimental Model. QUAN, quantitative data, QUAL, qualitative data.
Figure 2
Figure 2
The flow of patients through the trial.
See this image and copyright information in PMC

References

    1. Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study . Heart 2001;86:516–21 - PMC - PubMed
    1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study . JAMA 2001;285:2370–5 - PubMed
    1. Ruigomez A, Johansson S, Wallander MA, et al. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK . BMC Cardiovasc Disord 2005;5:20. - PMC - PubMed
    1. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery Camm AJ, Kirchhof P, Lip GYet al. Guidelines for the management of atrial fibrillation: the Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) . Europace 2010;12:1360–420 - PubMed
    1. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, et al. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atral fibrillation (Review) 2009;The Cochrane Libraly(1) - PubMed

Associated data

LinkOut - more resources